Induction of homologue of slimb ubiquitin ligase receptor by mitogen signaling

被引:57
作者
Spiegelman, VS
Tang, WG
Chan, AM
Igarashi, M
Aaronson, SA
Sassoon, DA
Katoh, M
Slaga, TJ
Fuchs, SY
机构
[1] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA
[2] AMC Canc Res Ctr, Lakewood, CO 80214 USA
[3] Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[4] Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA
[5] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan
关键词
D O I
10.1074/jbc.M204524200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Homologue of Slimb (HOS) is the substrate-recognizing component of the SCFHOS-Roc1 E3 ubiquitin protein ligase. This ligase mediates ubiquitination of the inhibitor of NF-kappaB transcription factor (IkappaB). We have found that HOS is highly expressed in a number of human cancer cell lines. The rates of the HOS gene transcription as well as HOS mRNA and protein levels were upregulated in cells treated with mitogens or transfected with the inducers of mitogen-activated protein kinase pathway. Conversely, mitogen withdrawal strikingly reduced HOS levels during differentiation of mouse myoblasts. Activators of mitogen-activated protein kinase accelerated IkappaBalpha degradation and increased NF-kappaB transcriptional activity. Inhibition of HOS function via expression of dominant negative HOS (HOSDeltaF) initiated mouse myoblast differentiation and prevented Ras-mediated acceleration of IkappaBalpha degradation as well as NF-kappaB trans-activation and transformation of NIH3T3 cells. These data link the induction of HOS in proliferating cells with mitogen-signaling-dependent inhibition of cell differentiation and promotion of cell transformation.
引用
收藏
页码:36624 / 36630
页数:7
相关论文
共 51 条
[1]   Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells [J].
Arsura, M ;
Mercurio, F ;
Oliver, AL ;
Thorgeirsson, SS ;
Sonenshein, GE .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) :5381-5391
[2]   Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts [J].
Bafico, A ;
Gazit, A ;
Wu-Morgan, SS ;
Yaniv, A ;
Aaronson, SA .
ONCOGENE, 1998, 16 (21) :2819-2825
[3]   Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-κB [J].
Bhatia, N ;
Herter, JR ;
Slaga, TJ ;
Fuchs, SY ;
Spiegelman, VS .
ONCOGENE, 2002, 21 (10) :1501-1509
[4]   The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB [J].
Bour, S ;
Perrin, C ;
Akari, H ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :15920-15928
[5]  
CAMPBELL JS, 1995, RECENT PROG HORM RES, V50, P131
[6]   HUMAN ONCOGENE OF THE RAS SUPERFAMILY UNMASKED BY EXPRESSION CDNA CLONING [J].
CHAN, AML ;
MIKI, T ;
MEYERS, KA ;
AARONSON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7558-7562
[7]  
CUADRADO A, 1993, ONCOGENE, V8, P2443
[8]   Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation [J].
Desbois-Mouthon, C ;
Cadoret, A ;
Blivet-Van Eggelpoël, MJ ;
Bertrand, F ;
Cherqui, G ;
Perret, C ;
Capeau, J .
ONCOGENE, 2001, 20 (02) :252-259
[9]   SCF and cullin/RING H2-based ubiquitin ligases [J].
Deshaies, RJ .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :435-467
[10]  
DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302